Department News

---

Oct 19, 2021

The new Center for Drug Discovery was featured on Channel 9 news. On the day of its airing the story, titled “New tool to help speed up life-saving drug treatments,” received the most views on the station’s Youtube channel!

Oct 19, 2021

A cutting-edge robot that will cut screening time for new drugs in half to get more effective therapies to people and animals is busy doing lifesaving work. Professor Dan LaBarbera, PhD is the founding director of the Center for Drug Discovery at CU Anschutz.

Oct 12, 2021

The news of the first antiviral pill to treat COVID-19 is a “very exciting development,” says Peter Anderson, PharmD, a professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz. He believes that oral pills taken at home, in combination with other medications, are the future of COVID treatments.

Oct 4, 2021

A new CU School of Pharmacy Drug Discovery Center brings one-of-a-kind technology to the Rocky Mountain region that could turn the campus into a hub for breakthrough drug therapies.

Sep 30, 2021

The Skaggs Scholars Program awards research grants to recipients from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences.

Sep 29, 2021

Professor Krishna Mallela, PhD, along with Vaibhav Upadhyay, Alexandra Lucas, Sudipta Panja, and Ryuki Miyauchi had research published in the Journal of Biological Chemistry. Dr. Mallela was also featured in this Discover magazine article title, “How COVID-19 Variants Could Outsmart Vaccines,” in which he discusses the implications of this research.

Sep 20, 2021

Professor David Kroll, PhD, spoke with CGTN America regarding the use of ivermectin, saying that patients should be empowered to be partners in their own healthcare, but certain organizations have lead those who are skeptical of the vaccine astray. Dr. Kroll says vaccines are the best COVID fighters, and he worries that the resolution of the pandemic will be prolonged by misinformation.

Jul 21, 2021

Pharmacogenomics, known as personalized medicine, is allowing pharmacy experts to design custom drugs and treatment approaches based on an individual's genome.

Jul 8, 2021

Dmitri Simberg, PhD, an associate professor in the Department of Pharmaceutical Sciences in the Skaggs School of Pharmacy and a CU Cancer Center member, has released the results of a new study of the effectiveness of different types of fluorescent labels used to monitor the accumulation of liposomes in tumors.

May 21, 2021

Master of Science student Glenn Harter plans to continue his education with a PhD, and his time at CU proved to be a valuable step in his life goal.

May 13, 2021

Heim Award honors two students who excelled in graduate research in 2020; one in HIV prevention, and another in Parkinson's disease.

Jan 7, 2021

Professor David Kroll served as the featured expert in an article on a state representative who is encouraging followers to use ivermectin, instead of a vaccine to prevent against COVID-19 infection. Ivermectin is an anti-parasitic drug widely used for livestock and pets.